An Australian-led research project at the Garvan Institute, funded by the National Health and Medical Research Council, is recruiting volunteers for a 3-year study examining the effects of metformin on cognition, brain anatomy and early signs of dementia.

We’re looking for people who meet the following eligibility criteria:

Metformin is a safe medication used to treat diabetes, but also other metabolic/hormonal conditions.

Our aims are to slow loss of memory and other aspects of cognition with ageing, and examine whether metformin affects other aspects of metabolism, inflammation and the ageing process.

Our team is made up of leading Australian and US dementia researchers.

For more information, contact by telephone or email:

This study is funded by the National Health and Medical Research Council (#1171665)

This study has been approved by the St Vincent’s Hospital Human Research Ethics Committee   

A study recruiting volunteers for a 3-year study examining the effects of metformin on cognition, brain anatomy and early signs of dementia.